Chinese researchers develop immunotherapeutic agent for colon cancer
Release time:2024-05-21 21:11:52
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for 。
TIANJIN, March 15 (Xinhua) -- Chinese researchers have developed a novel immunotherapeutic agent for treating colon cancer, according to a recent article in the academic journal ACS Nano. In animal experiments, the agent, upon successful entry into tumor cells, can enhance T cell effector function to kill tumor cells and suppress colon tumor growth, according to Lu Chunwan from the School of Life Sciences of Tianjin University, one of the authors of the article. The agent can enhance tumor immunogenicity and inhibit colon tumor growth, with no significant impact on normal cells, said Lu. Colon cancer, characterized by its long latency period and high mortality rate, poses a severe threat to human health. Among various therapies, immunotherapy is considered one of the most promising treatment directions, according to Lu.
(Editor:Fu Bo)
Related articles
- Kid Rock wielded a gun, hurled racial slurs, and instigated a physical altercation with a reporter,2024-05-21
Messi in starting lineup for Inter Miami's match against DC United
FORT LAUDERDALE, Fla. (AP) — Lionel Messi returned to the starting lineup for Inter Miami’s match ag2024-05-21Jaime Torres wins the Preakness with Seize the Grey 2 years after starting to ride horses
BALTIMORE (AP) — Jaime Torres was watching horse racing on television in his native Puerto Rico in 22024-05-21F1 marks 30th anniversary of Senna's death at Imola and Norris tries to follow up Miami win
Formula 1 arrives at the Emilia Romagna Grand Prix with a look to the past — it’s 30 years since Ayr2024-05-21Who is Jacob Zuma, the former South African president disqualified from next week's election?
JOHANNESBURG (AP) — Former South African President Jacob Zuma was barred Monday from running for Par2024-05-21EU changes pace on migration and asylum policy
People spend time under wisteria flowers at Villa Bardini in Florence, Italy, on April 24, 2023. [Ph2024-05-21
atest comment